PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC

May 1, 2019, 00:00
10.1016/j.jval.2019.04.1341
https://www.valueinhealthjournal.com/article/S1098-3015(19)31533-5/fulltext
Title : PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31533-5&doi=10.1016/j.jval.2019.04.1341
First page :
Section Title :
Open access? : No
Section Order : 10838
Categories :
Tags :
Regions :
ViH Article Tags :